Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

FLNA

Filana Therapeutics Inc

May 01 • 04:00PM ET

1.51

+0.06 4.14 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: BIIB LLY AVXL SRPT ANVS ACLX PRTA AXSM FATE XERS

| Held by: VTI VXF VHT IWC DFAS AVSC QQQS BTEC DFMC DCOR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.88	Insider Own	6.33%	Shs Outstand	48.31M	Perf Week	-6.21%
Market Cap	72.94M	Forward P/E	-	EPS next Y	-	Insider Trans	8.21%	Shs Float	45.25M	Perf Month	-12.21%
Enterprise Value	-22.56M	PEG	-	EPS next Q	-0.23	Inst Own	28.46%	Short Float	15.31%	Perf Quarter	-24.12%
Income	-90.97M	P/S	-	EPS this Y	45.74%	Inst Trans	-0.21%	Short Ratio	12.80	Perf Half Y	-55.85%
Sales	0.00M	P/B	0.98	EPS next Y	-	ROA	-65.95%	Short Interest	6.93M	Perf YTD	-23.74%
Book/sh	1.54	P/C	0.76	EPS next 5Y	-	ROE	-82.66%	52W High	4.98 -69.68%	Perf Year	-6.79%
Cash/sh	1.98	P/FCF	-	EPS past 3/5Y	0.23% -50.67%	ROIC	-122.27%	52W Low	1.39 8.63%	Perf 3Y	-93.53%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.40% 5.70%	Perf 5Y	-96.77%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-327.51%	Oper. Margin	-	ATR (14)	0.10	Perf 10Y	-91.09%
Dividend Ex-Date	Dec 13, 2012	Quick Ratio	2.23	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	37.27	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.23	EPS Q/Q	54.76%	SMA20	-7.50%	Beta	-0.76	Target Price	8.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-18.70%	Rel Volume	1.54	Prev Close	1.45
Employees	20	LT Debt/Eq	0.00	Earnings	Mar 12 BMO	SMA200	-38.51%	Avg Volume	541.27K	Price	1.51
IPO	Jul 14, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	13.33% -	Trades		Volume	834,831	Change	4.14%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)